
Binta M. Robinson
Examiner (ID: 15963)
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625, 1612, 1614 |
| Total Applications | 611 |
| Issued Applications | 413 |
| Pending Applications | 22 |
| Abandoned Applications | 176 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5416980
[patent_doc_number] => 20090042867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-12
[patent_title] => 'COMPOUNDS FOR THE TREATMENT OF ALZHEIMER\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/063304
[patent_app_country] => US
[patent_app_date] => 2006-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21509
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20090042867.pdf
[firstpage_image] =>[orig_patent_app_number] => 12063304
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/063304 | COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | Aug 7, 2006 | Abandoned |
Array
(
[id] => 4792706
[patent_doc_number] => 20080293680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => 'Substituted Ethane-1,2-Diamines for the Treatment of Alzheimer\'s Disease II'
[patent_app_type] => utility
[patent_app_number] => 11/997449
[patent_app_country] => US
[patent_app_date] => 2006-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16450
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20080293680.pdf
[firstpage_image] =>[orig_patent_app_number] => 11997449
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/997449 | Substituted Ethane-1,2-Diamines for the Treatment of Alzheimer's Disease II | Jul 31, 2006 | Abandoned |
Array
(
[id] => 5563699
[patent_doc_number] => 20090136551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'Substituted Dicyanoalkanes For Combating Animal Pests'
[patent_app_type] => utility
[patent_app_number] => 11/997166
[patent_app_country] => US
[patent_app_date] => 2006-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27624
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20090136551.pdf
[firstpage_image] =>[orig_patent_app_number] => 11997166
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/997166 | Substituted Dicyanoalkanes For Combating Animal Pests | Jul 31, 2006 | Abandoned |
Array
(
[id] => 4444
[patent_doc_number] => 07816378
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-19
[patent_title] => 'Cyclic ketal beta-secretase inhibitors for the treatment of alzheimer\'s disease'
[patent_app_type] => utility
[patent_app_number] => 11/989990
[patent_app_country] => US
[patent_app_date] => 2006-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9632
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/816/07816378.pdf
[firstpage_image] =>[orig_patent_app_number] => 11989990
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/989990 | Cyclic ketal beta-secretase inhibitors for the treatment of alzheimer's disease | Jul 27, 2006 | Issued |
Array
(
[id] => 151979
[patent_doc_number] => 07678809
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-16
[patent_title] => 'Benzimidazole compounds having nociceptin receptor affinity'
[patent_app_type] => utility
[patent_app_number] => 11/494826
[patent_app_country] => US
[patent_app_date] => 2006-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4825
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/678/07678809.pdf
[firstpage_image] =>[orig_patent_app_number] => 11494826
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/494826 | Benzimidazole compounds having nociceptin receptor affinity | Jul 27, 2006 | Issued |
Array
(
[id] => 5254043
[patent_doc_number] => 20070135499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Hydrazide compounds'
[patent_app_type] => utility
[patent_app_number] => 11/485182
[patent_app_country] => US
[patent_app_date] => 2006-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 23283
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20070135499.pdf
[firstpage_image] =>[orig_patent_app_number] => 11485182
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/485182 | Hydrazide compounds | Jul 10, 2006 | Abandoned |
Array
(
[id] => 4760018
[patent_doc_number] => 20080312244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'Squaric Acid Derivatives as Protein Kinase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/997036
[patent_app_country] => US
[patent_app_date] => 2006-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17703
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20080312244.pdf
[firstpage_image] =>[orig_patent_app_number] => 11997036
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/997036 | Squaric Acid Derivatives as Protein Kinase Inhibitors | Jun 29, 2006 | Abandoned |
Array
(
[id] => 13804
[patent_doc_number] => 07807692
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-05
[patent_title] => 'Antidiabetic oxazolidinediones and thiazolidinediones'
[patent_app_type] => utility
[patent_app_number] => 11/922628
[patent_app_country] => US
[patent_app_date] => 2006-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21546
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/807/07807692.pdf
[firstpage_image] =>[orig_patent_app_number] => 11922628
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/922628 | Antidiabetic oxazolidinediones and thiazolidinediones | Jun 29, 2006 | Issued |
Array
(
[id] => 5851826
[patent_doc_number] => 20060235017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Cytokine Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/426603
[patent_app_country] => US
[patent_app_date] => 2006-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22582
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20060235017.pdf
[firstpage_image] =>[orig_patent_app_number] => 11426603
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/426603 | Cytokine inhibitors | Jun 26, 2006 | Issued |
Array
(
[id] => 5242939
[patent_doc_number] => 20070021434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'NON-NUCLEOSIDE ANTI-HEPACIVIRUS AGENTS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/426580
[patent_app_country] => US
[patent_app_date] => 2006-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 55
[patent_no_of_words] => 91221
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20070021434.pdf
[firstpage_image] =>[orig_patent_app_number] => 11426580
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/426580 | NON-NUCLEOSIDE ANTI-HEPACIVIRUS AGENTS AND USES THEREOF | Jun 25, 2006 | Abandoned |
Array
(
[id] => 5000456
[patent_doc_number] => 20070043090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-22
[patent_title] => 'Novel Sulfonamides'
[patent_app_type] => utility
[patent_app_number] => 11/426482
[patent_app_country] => US
[patent_app_date] => 2006-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3771
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20070043090.pdf
[firstpage_image] =>[orig_patent_app_number] => 11426482
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/426482 | Sulfonamides | Jun 25, 2006 | Issued |
Array
(
[id] => 5142567
[patent_doc_number] => 20070004783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Crystalline forms of amlodipine maleate'
[patent_app_type] => utility
[patent_app_number] => 11/425639
[patent_app_country] => US
[patent_app_date] => 2006-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2663
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20070004783.pdf
[firstpage_image] =>[orig_patent_app_number] => 11425639
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/425639 | Crystalline forms of amlodipine maleate | Jun 20, 2006 | Abandoned |
Array
(
[id] => 5142556
[patent_doc_number] => 20070004772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Triazolopyridine cannabinoid receptor 1 antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/454322
[patent_app_country] => US
[patent_app_date] => 2006-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58297
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20070004772.pdf
[firstpage_image] =>[orig_patent_app_number] => 11454322
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/454322 | Triazolopyridine cannabinoid receptor 1 antagonists | Jun 15, 2006 | Issued |
Array
(
[id] => 4534145
[patent_doc_number] => 07872026
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-18
[patent_title] => 'Ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof'
[patent_app_type] => utility
[patent_app_number] => 11/448782
[patent_app_country] => US
[patent_app_date] => 2006-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12802
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/872/07872026.pdf
[firstpage_image] =>[orig_patent_app_number] => 11448782
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/448782 | Ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof | Jun 7, 2006 | Issued |
Array
(
[id] => 5700664
[patent_doc_number] => 20060217349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain'
[patent_app_type] => utility
[patent_app_number] => 11/445424
[patent_app_country] => US
[patent_app_date] => 2006-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4198
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20060217349.pdf
[firstpage_image] =>[orig_patent_app_number] => 11445424
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/445424 | Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain | May 31, 2006 | Issued |
Array
(
[id] => 5324359
[patent_doc_number] => 20090062349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => '1-Hydroxycycloalkanecarboxamide derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/920306
[patent_app_country] => US
[patent_app_date] => 2006-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15574
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20090062349.pdf
[firstpage_image] =>[orig_patent_app_number] => 11920306
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/920306 | 1-hydroxycycloalkanecarboxamide derivatives | May 29, 2006 | Issued |
Array
(
[id] => 5859930
[patent_doc_number] => 20060229326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Pyridine-3-carboxamide derivatives as CB1 inverse agonists'
[patent_app_type] => utility
[patent_app_number] => 11/397743
[patent_app_country] => US
[patent_app_date] => 2006-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29068
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20060229326.pdf
[firstpage_image] =>[orig_patent_app_number] => 11397743
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/397743 | Pyridine-3-carboxamide derivatives as CB1 inverse agonists | Apr 3, 2006 | Issued |
Array
(
[id] => 112725
[patent_doc_number] => 07713961
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-11
[patent_title] => 'Substituted 1,2-ethylenediamines, methods for preparing them and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/278059
[patent_app_country] => US
[patent_app_date] => 2006-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37068
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/713/07713961.pdf
[firstpage_image] =>[orig_patent_app_number] => 11278059
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/278059 | Substituted 1,2-ethylenediamines, methods for preparing them and uses thereof | Mar 29, 2006 | Issued |
Array
(
[id] => 53973
[patent_doc_number] => 07767625
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-03
[patent_title] => 'Carboxanilides as microbiocides'
[patent_app_type] => utility
[patent_app_number] => 11/909389
[patent_app_country] => US
[patent_app_date] => 2006-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19696
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/767/07767625.pdf
[firstpage_image] =>[orig_patent_app_number] => 11909389
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/909389 | Carboxanilides as microbiocides | Mar 20, 2006 | Issued |
Array
(
[id] => 5924526
[patent_doc_number] => 20060241148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'Fluorinated pyridine N-oxide thrombin modulators and process for N-oxidation of nitrogen containing heteroaryls'
[patent_app_type] => utility
[patent_app_number] => 11/385056
[patent_app_country] => US
[patent_app_date] => 2006-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12323
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20060241148.pdf
[firstpage_image] =>[orig_patent_app_number] => 11385056
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/385056 | Fluorinated pyridine N-oxide thrombin modulators and process for N-oxidation of nitrogen containing heteroaryls | Mar 20, 2006 | Issued |